title: New physiopathological and therapeutic approaches to diverticular disease of the colon.
abstract: Diverticular disease of the colon is among the most common diseases of westernised and industrialised countries. Its prevalence is approximately 5-10% of people up to 50 years of age, 30% of those > 50 years of age, and 50% of those > 70 years of age, and 66% of people > 85 years of age. Standard medical therapies with antibiotics are still the recommended treatment. However, changing concepts and new therapies recently found that anti-inflammatory agents, such as mesalazine (alone or in combination with antibiotics) and probiotics, may be useful in shortening the course of the disease and perhaps in preventing recurrences.
authors.affiliation: Lorenzo Bonomo Hospital, Digestive Endoscopy Unit, Via Torino, 49, 70031 Andria, BA, Italy. antotursi@tiscali.it
authors.forename: Antonio
authors.initials: A
authors.lastname: Tursi
mesh_terms: D003106:Colon / Q000187:drug effects / Q000502:physiology; D004239:Diverticulitis, Colonic / Q000188:drug therapy* / Q000503:physiopathology*; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans
chemical_list: D015507:Drugs, Investigational